Interim FDA Chief on Leave From Day Job
From Times Wire Reports
Andrew von Eschenbach, named last week as interim Food and Drug Administration commissioner to replace Lester Crawford, will take a leave of absence from his job as director of the National Cancer Institute, Sen. Barbara Mikulski said.
Von Eschenbach also will “refrain from selected FDA activities that may be seen as a conflict of interest,” Mikulski, a Maryland Democrat, said in a statement.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
